MS

Morgan Stanley Asia

North America, New York, United States, New York

Description

Morgan Stanley Private Equity Asia (MSPEA) is the dedicated private equity investment arm of Morgan Stanley, primarily focused on the dynamic Asia-Pacific region. Established as a significant player in the private equity landscape, MSPEA specializes in making control and significant minority investments in well-established companies. Its strategy revolves around partnering with strong management teams to drive growth and operational improvements, leveraging Morgan Stanley's extensive global network and resources. The firm targets businesses with proven track records and substantial growth potential across various sectors, aiming for long-term value creation.

MSPEA's investment mandate spans a diverse range of industries, including consumer, healthcare, manufacturing, financial services, and technology. Geographically, its focus is broad within Asia, encompassing key markets such as China, India, Korea, Southeast Asia, Australia, and Japan. The team's deep regional expertise and local presence enable them to identify compelling investment opportunities and navigate complex market dynamics. They typically seek companies that are leaders or strong contenders within their respective niches, capable of benefiting from strategic capital infusion and operational enhancement.

The firm manages substantial capital, reflecting its significant presence in the Asian private equity market. For instance, its fifth flagship fund, Morgan Stanley Private Equity Asia V, successfully closed in 2018 with commitments totaling approximately $1.7 billion. This capital is deployed into a portfolio of companies, with typical first cheque sizes ranging from approximately $50 million to $250 million, depending on the specific opportunity and the equity stake sought. MSPEA targets companies that are poised for significant expansion, often through market consolidation, product innovation, or geographic expansion.

MSPEA's long-standing commitment to the Asia-Pacific market, coupled with its robust financial backing and strategic approach, positions it as a prominent investor for mature, high-growth companies in the region. The firm's ability to provide both capital and strategic guidance makes it a preferred partner for businesses seeking to scale and achieve their next phase of development.

Investor Profile

Morgan Stanley Asia has backed more than 40 startups, with 3 new investments in the last 12 months alone. The firm has led 15 rounds, about 38% of its total and boasts 25 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Private Equity, Post Ipo Secondary, Post Ipo Equity rounds (top funding stages).
  • Majority of deals are located in India, China, Hong Kong.
  • Strong thematic focus on Manufacturing, Financial Services, Health Care.
  • Typical check size: $50M – $250M.

Stage Focus

  • Private Equity (43%)
  • Post Ipo Secondary (28%)
  • Post Ipo Equity (23%)
  • Undisclosed (3%)
  • Series D (3%)
  • Seed (3%)

Country Focus

  • India (55%)
  • China (18%)
  • Hong Kong (8%)
  • Taiwan (5%)
  • South Korea (5%)
  • United Arab Emirates (3%)
  • United States (3%)
  • Austria (3%)
  • Singapore (3%)

Industry Focus

  • Manufacturing
  • Financial Services
  • Health Care
  • Finance
  • Real Estate
  • Insurance
  • Wellness
  • Health Insurance
  • Banking
  • E-commerce
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Morgan Stanley Asia frequently co-invest with?

Co-Investments: 3
Societe Generale
Europe, Ile-de-France, France, Paris
Co-Investments: 8
Goldman Sachs (Singapore) Pte
Asia, Central Region, Singapore, Singapore
Co-Investments: 5
BP
Europe, Ile-de-France, France, Paris
Co-Investments: 3
ICICI Prudential Life Insurance
Asia, Maharashtra, India, Mumbai
Co-Investments: 3
Government of Singapore
Asia, Central Region, Singapore, Singapore
Co-Investments: 3
Axis Mutual Fund
Asia, Maharashtra, India, Mumbai
Co-Investments: 3
Abu Dhabi Investment Authority
Asia, Abu Dhabi, United Arab Emirates, Abu Dhabi
Co-Investments: 2
Invesco Mutual Fund
Asia, Maharashtra, India, Mumbai
Co-Investments: 2
CM
Africa, Port Louis, Mauritius, Port Louis
Co-Investments: 3

Which angels does Morgan Stanley Asia often collaborate with?

AB
Asia, Maharashtra, India, Mumbai
Shared Deals: 1

What are some of recent deals done by Morgan Stanley Asia?

IREDA is a Mini Ratna Government of India Enterprise under the administrative control of Ministry of New and Renewable Energy.

Post Ipo EquityJun 11, 2025
Amount Raised: $234,661,712
Aptus Value Housing Finance India

Chennai, Tamil Nadu, India

Aptus is a company engaged in Affordable housing finance

BankingFinanceFinancial Services
Post Ipo SecondaryJun 3, 2025
Amount Raised: $222,380,250
SpiceJet Limited

Haryana, Haryana, India

SpiceJet is India’s preferred airline, with 18.5% market share in Indian domestic market, delivering the lowest air fares with the highest

AerospaceTransportationTravel
Post Ipo EquitySep 17, 2024
Amount Raised: $358,119,774
Jupiter Wagons

Kolkata, West Bengal, India

Jupiter Wagons provides transportation solutions, including the manufacture of railway equipment, passenger coaches, and castings.

Industrial ManufacturingManufacturingMechanical EngineeringRailroadTransportation
Post Ipo EquityJul 12, 2024
Amount Raised: $95,787,464
IndiaMART

Noida, Uttar Pradesh, India

IndiaMART.com is an online B2B marketplace connecting buyers with suppliers.

B2BE-CommerceMarketplaceProcurementSmall and Medium Businesses
Post Ipo SecondaryJun 21, 2024
Amount Raised: $22,721,126
Aster DM Healthcare

Dubai, Dubai, United Arab Emirates

Headquartered in Dubai, the journey towards excellence in Healthcare was started by Dr. Azad Moopen, a doctor turned entrepreneur.

Health CareHospitalWellness
Post Ipo SecondaryJun 21, 2024
Amount Raised: $183,068,261
Omega Hospitals

Hyderabad, Andhra Pradesh, India

Omega Hospitals provides specialized cancer treatment services, including medical, surgical, and radiation oncology.

Health CareHospitalMedicalWellness
Private EquityJun 19, 2024
Amount Raised: $59,941,150
Timken India

Bangalore, Karnataka, India

Timken India is a Ball and roller bearing manufacturing company.

Manufacturing
Post Ipo SecondaryMay 28, 2024
Amount Raised: $235,157,959
Apollo Tyres

Gurgaon, Haryana, India

Apollo Tyres is an automotive company that specializes in tire manufacturing.

AutomotiveManufacturingProduct Design
Post Ipo SecondaryMay 22, 2024
Amount Raised: $128,850,098
DB Realty

Goregaon, Maharashtra, India

DB Realty is one of India's leading real estate developer offering residential luxury flats and commercial projects in Mumbai.

Real Estate
Post Ipo EquityMar 13, 2024
Amount Raised: $111,066,502